Back to Search Start Over

Lessons from the withdrawal of rofecoxib: France has policy for overall assessment of public health impact of new drugs.

Authors :
Abenhaim L
Source :
BMJ (Clinical research ed.) [BMJ] 2004 Dec 04; Vol. 329 (7478), pp. 1342.
Publication Year :
2004

Subjects

Subjects :
Adverse Drug Reaction Reporting Systems legislation & jurisprudence
France
Health Policy
Humans
Sulfones
Anti-Inflammatory Agents, Non-Steroidal adverse effects
Drug Approval
Lactones adverse effects

Details

Language :
English
ISSN :
1756-1833
Volume :
329
Issue :
7478
Database :
MEDLINE
Journal :
BMJ (Clinical research ed.)
Publication Type :
Editorial & Opinion
Accession number :
15576748
Full Text :
https://doi.org/10.1136/bmj.329.7478.1342-a
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details